The Model-Informed Drug Development (MIDD) Discussion Group was established in January 2021 and has provided as an output considerations with respect to future MIDD related guidelines in the form of a “roadmap”.
Related guidelines
Harmonised
M15
M15 – General Principles for Model-Informed Drug Development